HCV - Liver Cirrhosis
Selected Hepatitis C Patients with Decompensated Cirrhosis Can Benefit from Interferon-based Therapy prior to Liver Transplantation - 6/10/08Natural History of HCV-Related Cirrhosis after Liver Transplantation - 5/08/08Pegylated Interferon plus Ribavirin for Patients with HCV-related Liver Cirrhosis - 3/11/08Non-Invasive Ways to Assess Liver Disease: Studies Test Alternatives to Liver Biopsy - 2/05/08 Human Genetic Variation May Protect Against HCV-related Liver Disease Progression - 1/04/08 Non-invasive FibroTest and FibroScan Predict Liver Cirrhosis Better than Earlier Stages of Fibrosis in Hepatitis C Patients - 12/11/07CD4 Cell Count Preferred over CD4 Cell Percentage for Monitoring HIV Disease Progression in People with Cirrhosis - 8/21/07
Treatment with Pegasys Plus Ribavirin in Genotype 2/3 Chronic Hepatitis C Patients with Liver Cirrhosis - 5/22/07
Transient Elastography as a Non-invasive Method for Predicting Portal Hypertension in Patients with Hepatitis C-related Cirrhosis - 5/18/07 Racial Disparities in Treatment of Patients with Cirrhosis and Complications of Portal Hypertension - 5/15/07 Sustained Response to Interferon Monotherapy Reduces Rates of Liver Cancer and Death in Patients with HCV-related Cirrhosis - 3/27/07Impact of Cirrhosis on CD4 Cell Counts in HIV Negative Individuals Has Implications for HIV-HCV and HIV-HBV Coinfected Patients 1/29/07Treatment of Hepatitis C in Patients with Advanced Fibrosis or Cirrhosis 12/08/06
FDA-approved Combination Therapies for Chronic HCV Infection
Pegasys + Copegus PEG-Intron + Rebetol Intron A + Rebetol Roferon A + Ribavirin Treatment Guidelines
HCV Articles by Topic
HCV Liver Issues Cirrhosis Fibrosis Hepatocellular Carcinoma Liver Transplantation Liver Biopsy Steatosis